TickerFacts.

Company research / ANVS

Annovis Bio, Inc. (ANVS)

Build a valuation ↗↓ Download CSV

CIK 0001477845 · NYSE · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Annovis Bio, Inc. reported revenue of $0.

Key ratios (year ended 2025-12-31)

-171.2%
Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 10-Q · 2026-08-14

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended2025-12-312024-12-312023-12-312022-12-312022-09-302022-06-302022-03-312021-12-312020-12-312019-12-31
Revenue$0$0$0$0———$0$0—
Operating Income-$29.70M-$26.69M-$45.04M-$25.51M———-$14.54M-$6.64M-$1.61M
Net Income-$28.85M-$24.59M-$56.20M-$25.33M———-$14.49M-$5.46M-$991.0K
EPS (Diluted)$-1.40$-2.31$-6.23$-3.10———$-1.90$-0.87—
Total Assets$21.08M$13.93M$10.21M$36.02M$37.12M$39.97M$44.10M$46.00M$8.12M$1.12M
Total Liabilities$4.23M$4.62M$17.96M$7.70M$2.53M$1.30M$1.40M$1.51M$578.4K$2.62M
Shareholders' Equity$16.85M$9.31M-$7.75M$28.32M$34.59M$38.67M$42.70M$44.49M$7.54M-$8.58M
Cash & Equivalents$19.53M$10.55M$5.75M$28.38M$31.99M$35.97M$42.67M$45.69M$8.07M$1.9K
Operating Cash Flow-$25.62M-$21.89M-$39.97M-$17.31M———-$9.13M-$3.97M-$476.5K
Shares Outstanding27.20M14.14M10.52M8.16M8.16M8.16M8.16M8.10M6.89M282.6K
Weighted Average Diluted Shares20.55M12.24M9.02M8.16M———7.63M6.31M—
EPS (Basic)$-1.40$-2.02$-6.23$-3.10———$-1.90$-0.87—